Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE